Detail
| LncRNA Name | MEG3 |
| Synonyms | MEG3, FP504, GTL2, LINC00023, NCRNA00023, PRO0518, PRO2160, onco-lncRNA-83, prebp1 |
| Region | GRCh38_14:100779410-100861031 Sequence |
| Ensembl | ENSG00000214548 |
| RefSeq | NR_002766 |
| Circulating | ✔ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR etc. |
| Sample | serum, urine, bladder cancer tissues |
| Expression Pattern | down-regulated |
| Function Description | MEG3 was significantly down-regulated, SNHG16 and MALAT1 were significantly up-regulated in healthy vs. BCs and benign disease vs. BCs comparisons. |
| Pubmed ID | 27793008 |
| Year | 2016 |
| Title | Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer. |
| External Links |
| Links for MEG3 | GenBank HGNC lncrnadb Noncode |
| Links for bladder cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.